Dabrafenib Mesylate and Nexiclon XR Suspension
Determining the interaction of Dabrafenib Mesylate and Nexiclon XR Suspension and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dabrafenib
Brand name: Tafinlar
Synonyms: Dabrafenib
Generic Name: clonidine
Brand name: Catapres, Catapres-TTS, Duraclon, Kapvay, Catapres-TTS-1, Catapres-TTS-2, Catapres-TTS-3
Synonyms: Nexiclon XR (Oral), Nexiclon XR
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dabrafenib Mesylate-Nexium
- Dabrafenib Mesylate-Nexium (Esomeprazole Delayed-Release Capsules)
- Dabrafenib Mesylate-Nexium (Esomeprazole Powder for Suspension)
- Dabrafenib Mesylate-Nexium 24HR (Esomeprazole Delayed-Release Capsules)
- Dabrafenib Mesylate-NexIUM 24HR (Esomeprazole Delayed-Release Tablets)
- Dabrafenib Mesylate-Nexium Capsules
- Nexiclon XR Suspension-Dacarbazine
- Nexiclon XR Suspension-Dacarbazine Intravenous, Injection
- Nexiclon XR Suspension-Daclatasvir
- Nexiclon XR Suspension-Daclatasvir Dihydrochloride
- Nexiclon XR Suspension-Daclizumab
- Nexiclon XR Suspension-Daclizumab Subcutaneous